Extracellular vesicle‐packaged lncRNA from cancer‐associated fibroblasts promotes immune evasion by downregulating HLA‐A in pancreatic cancer
Journal of Extracellular Vesicles · 2024-07 · 13 (7)
DOI: 10.1002/jev2.12484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 23.07.2024. Verfasst von Hanming Yao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Scien…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Cancer-Associated Fibroblasts, Extracellular Vesicles, Pancreatic Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is characterised by immune evasion that contribute to poor prognosis. Cancer‐associated fibroblasts (CAFs) play a pivotal role in orchestrating the PDAC tumour microenvironment. We investigated the role of CAF‐derived extracellular vesicle (EV)‐packaged long non‐coding RNAs (lncRNAs) in immune evasion and explored gene therapy using engineered EVs loading small interfering RNAs (siRNAs) as a potential therapeutic strategy. Our findings highlight the significance of EV‐packaged lncRNA RP11‐161H23.5 from CAF in promoting PDAC immune evasion by downregulating HLA‐A expression, a key component of antigen presentation. Mechanistically, RP11‐161H23.5 forms a complex with CNOT4, a subunit of the mRNA deadenylase CCR4‐NOT complex, enhancing the degradation of HLA‐A mRNA by shortening its poly(A) tail. This immune evasion mechanism compromises the anti‐tumour immune response. To combat this, we propose an innovative approach utilising engineered EVs as natural and biocompatible nanocarriers for siRNA‐based gene therapy and this strategy holds promise for enhancing the effectiveness of immunotherapy in PDAC. Overall, our study sheds light on the critical role of CAF‐derived EV‐packaged lncRNA RP11‐161H23.5/CNOT4/HLA‐A axis in PDAC immune evasion and presents a novel avenue for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
- Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
- Department of Nephrology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Kaihong Huang
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Science and Technology Program of Guangzhou
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Yao, H., Huang, C., Zou, J., Liang, W., Zhao, Y., Yang, K., Zhong, Z., Zhou, S., Li, J., Li, Y., Xu, L., Huang, K., & Lian, G. (2024). Extracellular vesicle‐packaged lncRNA from cancer‐associated fibroblasts promotes immune evasion by downregulating HLA‐A in pancreatic cancer. Journal of Extracellular Vesicles, 13(7). https://doi.org/10.1002/jev2.12484
Vancouver
Yao H, Huang C, Zou J, Liang W, Zhao Y, Yang K, et al. Extracellular vesicle‐packaged lncRNA from cancer‐associated fibroblasts promotes immune evasion by downregulating HLA‐A in pancreatic cancer. Journal of Extracellular Vesicles. 2024;13(7). doi:10.1002/jev2.12484
BibTeX
@article{Yao2024,
author = {Yao, Hanming and Huang, Chengzhi and Zou, Jinmao and Liang, Weiling and Zhao, Yue and Yang, Kege and Zhong, Ziyi and Zhou, Shurui and Li, Jiajia and Li, Yaqing and Xu, Lishu and Huang, Kaihong and Lian, Guoda},
title = {Extracellular vesicle‐packaged lncRNA from cancer‐associated fibroblasts promotes immune evasion by downregulating HLA‐A in pancreatic cancer},
journal = {Journal of Extracellular Vesicles},
year = {2024},
volume = {13},
number = {7},
doi = {10.1002/jev2.12484}
}
EUVIMED